Premium
ICON PLC (ICLR)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laborator... Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. Show more
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of over 120 biotech and pharma professionals...
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 43rd Annual J.P...
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024. On TIME Magazine’s 2024...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced the appointment of Barry Balfe as Chief Operating Officer (COO). Barry is a...
Survey spotlights shifting expectations and more measured pace of innovation as use of digital solutions matures within the biotech and pharma industry ICON plc, (NASDAQ: ICLR) a world-leading...
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc and Mr. Nigel Clerkin, CFO of ICON plc...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 3.89 | 1.81495824196 | 214.33 | 228.285 | 211 | 768748 | 218.75812455 | CS |
| 4 | 7.42 | 3.51992409867 | 210.8 | 228.285 | 200.69 | 799853 | 209.89125661 | CS |
| 12 | -77.91 | -26.3093911458 | 296.13 | 301.455 | 183.38 | 1431050 | 217.88941508 | CS |
| 26 | -106.87 | -32.8739733612 | 325.09 | 347.7225 | 183.38 | 949562 | 247.32275291 | CS |
| 52 | -53.47 | -19.6805182377 | 271.69 | 347.7225 | 183.38 | 747401 | 267.6234798 | CS |
| 156 | -61.78 | -22.0642857143 | 280 | 347.7225 | 171.43 | 631655 | 243.56834824 | CS |
| 260 | 49.27 | 29.1624741048 | 168.95 | 347.7225 | 104.275 | 553417 | 233.26938063 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
